Europe Stocks Head Higher After Record Breaking US Session
Fiona Cincotta November 25, 2020 7:24 PM
After a record setting session in the US, EU stocks are heading broadly higher, although the pace of gains suggest that the risk rally is easing slightly

After a record setting session in the US, EU stocks are heading broadly higher, although the pace of gains suggest that the risk rally is easing slightly. Vaccine optimism, EU governments starting to ease lockdown restrictions and more US political clarity have driven stocks firmly higher across the start of the week. However, investors are now looking ahead to a slew of US data due later today for further cues ahead of the Thanksgiving break.
Today UK Chancellor Rishi Sunak’s one year spending review will be in focus. There are suggestions that the foreign aid budget will be cut in addition to a public sector pay freeze, which is likely to be met with a frosty reaction. More funds are also expected to be allocated to helping those get back into the labour market after the covid culling.
Oil prices continue to bound higher focusing on the prospect of a viable vaccine improving future demand, whilst shrugging off near term concerns of building crude supplies. US crude inventories rose by 3.8 million barrels last week according to the API, EIA data is due later today.
Looking ahead there are several key US economic reports that will be released, including GDP, jobless claims and durable goods which could provide plenty of volatility for trading opportunities.
FTSE Chart
The FTSE is edging higher after surging northwards earlier in the month. A break over resistance at 6510 could see the FTSE power higher towards resistance at 6670. On the flip side a break below 6300 a level which has offered support across the month could see FTSE head towards support at 6050 200 day sma.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.